Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review

DP Prata, B Costa-Neves, G Cosme… - Journal of psychiatric …, 2019 - Elsevier
Objectives To systematically review findings of GWAS in schizophrenia (SZ) and in bipolar
disorder (BD); and to interpret findings, with a focus on identifying independent replications …

[HTML][HTML] The human VRK1 chromatin kinase in cancer biology

I Campillo-Marcos, R García-González… - Cancer letters, 2021 - Elsevier
VRK1 is a nuclear Ser-Thr chromatin kinase that does not mutate in cancer, and is
overexpressed in many types of tumors and associated with a poor prognosis. Chromatin …

DNA cross-bridging shapes a single nucleus from a set of mitotic chromosomes

M Samwer, MWG Schneider, R Hoefler… - Cell, 2017 - cell.com
Eukaryotic cells store their chromosomes in a single nucleus. This is important to maintain
genomic integrity, as chromosomes packaged into separate nuclei (micronuclei) are prone …

Common variants at VRK2 and TCF4 conferring risk of schizophrenia

S Steinberg, S de Jong, OA Andreassen… - Human molecular …, 2011 - academic.oup.com
Common sequence variants have recently joined rare structural polymorphisms as genetic
factors with strong evidence for association with schizophrenia. Here we extend our …

VRK1 is a synthetic–lethal target in VRK2-deficient glioblastoma

JA Shields, SR Meier, M Bandi, EE Mulkearns-Hubert… - Cancer Research, 2022 - AACR
Synthetic lethality is a genetic interaction that results in cell death when two genetic
deficiencies co-occur but not when either deficiency occurs alone, which can be co-opted for …

[HTML][HTML] Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site

ED Scheeff, J Eswaran, G Bunkoczi, S Knapp… - Structure, 2009 - cell.com
About 10% of all protein kinases are predicted to be enzymatically inactive pseudokinases,
but the structural details of kinase inactivation have remained unclear. We present the first …

The FBXW2–MSX2–SOX2 axis regulates stem cell property and drug resistance of cancer cells

Y Yin, CM Xie, H Li, M Tan, G Chen… - Proceedings of the …, 2019 - National Acad Sciences
SOX2 is a key transcription factor that plays critical roles in maintaining stem cell property
and conferring drug resistance. However, the underlying mechanisms by which SOX2 level …

[HTML][HTML] VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system

J So, NW Mabe, B Englinger, KH Chow, SM Moyer… - JCI insight, 2022 - ncbi.nlm.nih.gov
Collateral lethality occurs when loss of a gene/protein renders cancer cells dependent on its
remaining paralog. Combining genome-scale CRISPR/Cas9 loss-of-function screens with …

Combination approaches to target PD-1 signaling in cancer

EK Moore, M Strazza, A Mor - Frontiers in immunology, 2022 - frontiersin.org
Cancer remains the second leading cause of death in the US, accounting for 25% of all
deaths nationwide. Immunotherapy techniques bolster the immune cells' ability to target …

The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer

PP Medina, SD Castillo, S Blanco… - Human molecular …, 2009 - academic.oup.com
The search for oncogenes is becoming increasingly important in cancer genetics because
they are suitable targets for therapeutic intervention. To identify novel oncogenes, activated …